Results 111 to 120 of about 47,907 (235)

The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma [PDF]

open access: yes, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/100150/1/cncy21286 ...
Betz, Bryan L.   +4 more
core   +1 more source

ALK Expression in Nerve Sheath Myxoma: A Potential Diagnostic Pitfall

open access: yes
Journal of Cutaneous Pathology, EarlyView.
Daniel Cole   +6 more
wiley   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

open access: yesClinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source

Anaplastic large cell lymphoma, ALK-negative

open access: yesCritical Reviews in Oncology/Hematology, 2013
Anaplastic large cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-negative (ALCL-ALK-) is a provisional entity in the WHO 2008 Classification that represents 2-3% of NHL and 12% of T-cell NHL. No particular risk factor has been clearly identified for ALCL, but a recent study showed an odds ratio of 18 for ALCL associated with breast implants ...
Ferreri, Andrés J.M.   +3 more
openaire   +3 more sources

Body height and the excess cancer risk in men

open access: yesInternational Journal of Cancer, Volume 158, Issue 3, Page 597-607, 1 February 2026.
What's new? In cancers that affect both sexes, men usually have a higher risk than women. While this is often attributed to behavioral factors, such as exposure to environmental carcinogens, there may be an intrinsic biological mechanism involved. Tall stature has been associated with increased cancer risk.
Cecilia Radkiewicz   +6 more
wiley   +1 more source

Sinus Histiocytosis with Massive Lymphadenopathy (Rosai Dorfman Disease) and Anaplastic Large Cell Lymphoma [PDF]

open access: yes
Sinus histiocytosis with massive lymphadenopathy (SHML) is a rare and benign source of lymphadenopathy first described in 1969. This disease commonly presents in children and young adults with supra-diaphragmatic lymphadenopathy mainly at cervical nodal ...
Garg, Kapil Kumar, Singh, Harpreet
core   +1 more source

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers [PDF]

open access: yes, 2012
Background: Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with 18F-fluorodeoxyglucose-positron-emission-tomography (PET).
Agostinelli, Claudio   +9 more
core   +1 more source

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP‐4 as Diagnostic and Predictive Biomarkers

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Paediatric classical Hodgkin lymphoma (cHL) is the most common malignancy in adolescents, and despite excellent survival, a subset of patients experiences treatment failure or severe long‐term toxicity, underscoring the need for improved risk stratification. Early response assessment is particularly important, as it guides decisions
Gustav Hedberg   +6 more
wiley   +1 more source

STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

open access: yesHaematologica, 2014
Systemic anaplastic large cell lymphoma is a category of T-cell non-Hodgkin’s lymphoma which can be further subdivided into two distinct entities (ALK+ and ALK−) based on the presence or absence of ALK gene rearrangements.
Elisa Spaccarotella   +15 more
doaj   +1 more source

Progress in RNA‐Targeted Therapeutics for Human Diseases

open access: yesMedComm, Volume 7, Issue 2, February 2026.
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy